Complications in Process Simulation Execution

Regulators have exaggerated expectations for simulated media fills.

In the late 1970s, media fill studies began to be used in aseptic processing for the expressed purpose of evaluating sterility assurance levels in filling activities. These initial studies were simplistic. In response to regulatory expectations, the activity grew in sophistication to address perceived vulnerabilities (1).

Read this article in Pharmaceutical Technology eBook: Biologics and Sterile Drug Manufacturing, May 2020, May 2020 Pages: 10–14

Article details

Pharmaceutical Technology eBook: Biologics and Sterile Drug Manufacturing
May 2020
Pages: 10–14

Citation

When referring to this article, please cite it as J. Agalloco, “Complications in Process Simulation Execution," Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2020).

Articles in this issue

over 5 years ago

Article

Minimizing Contamination During BioPharm R&D

over 5 years ago

Article

Trends and Formulation Strategies for Topical Drugs

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!